Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-4-8
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0887-6924
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
811-3
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12682645-Adult, pubmed-meshheading:12682645-Aged, pubmed-meshheading:12682645-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12682645-Blood Cell Count, pubmed-meshheading:12682645-Blood Component Removal, pubmed-meshheading:12682645-Cohort Studies, pubmed-meshheading:12682645-Combined Modality Therapy, pubmed-meshheading:12682645-Cost-Benefit Analysis, pubmed-meshheading:12682645-Female, pubmed-meshheading:12682645-Graft Survival, pubmed-meshheading:12682645-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:12682645-Hematopoietic Stem Cell Mobilization, pubmed-meshheading:12682645-Humans, pubmed-meshheading:12682645-Male, pubmed-meshheading:12682645-Middle Aged, pubmed-meshheading:12682645-Neoplasms, pubmed-meshheading:12682645-Peripheral Blood Stem Cell Transplantation, pubmed-meshheading:12682645-Recombinant Proteins, pubmed-meshheading:12682645-Retrospective Studies, pubmed-meshheading:12682645-Transplantation, Autologous
pubmed:year
2003
pubmed:articleTitle
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
pubmed:publicationType
Letter, Research Support, Non-U.S. Gov't